CODAGENIX INC has a total of 18 patent applications. It increased the IP activity by 1300.0%. Its first patent ever was published in 2017. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Brazil. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are THE GOVERNMENT OF THE US SECRETARY OF THE ARMY, ICO THERAPEUTICS INC and VIVIBABA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | Australia | 3 | |
#3 | Brazil | 2 | |
#4 | China | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Canada | 1 | |
#7 | Israel | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Singapore | 1 | |
#10 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Climate change adaptation technologies | |
#5 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Mueller Steffen | 15 |
#2 | Wang Ying | 14 |
#3 | Coleman John Robert | 14 |
#4 | Stauft Charles | 7 |
#5 | Yang Chen | 5 |
#6 | John Robert Coleman | 2 |
#7 | Steffen Mueller | 2 |
#8 | Ying Wang | 2 |
#9 | Collins Peter L | 1 |
#10 | Buchholz Ursula J | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020263850A1 | Attenuated dengue viruses | |
WO2020232254A1 | Attenuated yellow fever virus and uses thereof for the treatment of cancer | |
US2021000939A1 | Attenuated flaviviruses | |
WO2019126690A1 | Recombinant virus with codon-pair deoptimized region and uses thereof for the treatment of cancer |